PTEN and cancer: Interestingly, the combination of a conventional chemotherapeutic agent together with the suppression of a specific upregulated oncomiRNA makes cancer cells more sensitive to the treatment, in this case a proposed mechanism is the upregulation of PTEN (an important oncosuppressor that is often inactivated in different types of cancer) which is targeted from miR-21.